Gayle A. Dakof
Research Subjects
Gayle A. Dakof has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Howard A. Liddle
University of Miami Miller School of Medicine
4 shared publications Craig E. Henderson
Department of Psychology, Sam Houston State University
2 shared publicationsEliette Duarte
Juvenile Division, 11th Judicial Circuit, Miami Dade County Florida USA
2 shared publicationsHoward A. Liddle
Department of Public Health Sciences
2 shared publications- Maya Boustani
Loma Linda University
2 shared publications Paul E. Greenbaum
Department of Child and Family Studies, Louis de la Parte Florida Mental Health Institute, University of South Florida
2 shared publications
Latest Publications
- Open Access
- 1 April 2015
- Published by American Psychological Association (APA) in Journal of Family Psychology
- Vol. 29 (2) , 232-241
A randomized clinical trial of family therapy in juvenile drug court.
The objective of this article is to examine the effectiveness of 2 theoretically different treatments delivered in juvenile drug court--family therapy represented by multidimensional family therapy (MDFT) and group-based treatment represented by adolescent group therapy (AGT)--on offending and substance use. Intent-to-treat sample included 112 youth enrolled in juvenile drug court (primarily male [88%], and Hispanic [59%] or African American [35%]), average age 16.1 years, randomly assigned to either family therapy (n = 55) or group therapy (n = 57). Participants were assessed at baseline and 6, 12, 18 and 24 months following baseline. During the drug court phase, youth in both treatments showed significant reduction in delinquency (average d = .51), externalizing symptoms (average d = 2.32), rearrests (average d = 1.22), and substance use (average d = 4.42). During the 24-month follow-up, family therapy evidenced greater maintenance of treatment gains than group-based treatment for externalizing symptoms (d = 0.39), commission of serious crimes (d = .38), and felony arrests (d = .96). There was no significant difference between the treatments with respect to substance use or misdemeanor arrests. The results suggest that family therapy enhances juvenile drug court outcomes beyond what can be achieved with a nonfamily based treatment, especially with respect to what is arguably the primary objective of juvenile drug courts: reducing criminal behavior and rearrests. More research is needed on the effectiveness of juvenile drug courts generally and on whether treatment type and family involvement influence outcomes. Clinical Trials.gov, Identified NCT01668303.
- 1 April 2015
- Published by American Psychological Association (APA) in Journal of Family Psychology
- Vol. 29 (2) , 232-241
Open AccessA randomized clinical trial of family therapy in juvenile drug court.
The objective of this article is to examine the effectiveness of 2 theoretically different treatments delivered in juvenile drug court--family therapy represented by multidimensional family therapy (MDFT) and group-based treatment represented by adolescent group therapy (AGT)--on offending and substance use. Intent-to-treat sample included 112 youth enrolled in juvenile drug court (primarily male [88%], and Hispanic [59%] or African American [35%]), average age 16.1 years, randomly assigned to either family therapy (n = 55) or group therapy (n = 57). Participants were assessed at baseline and 6, 12, 18 and 24 months following baseline. During the drug court phase, youth in both treatments showed significant reduction in delinquency (average d = .51), externalizing symptoms (average d = 2.32), rearrests (average d = 1.22), and substance use (average d = 4.42). During the 24-month follow-up, family therapy evidenced greater maintenance of treatment gains than group-based treatment for externalizing symptoms (d = 0.39), commission of serious crimes (d = .38), and felony arrests (d = .96). There was no significant difference between the treatments with respect to substance use or misdemeanor arrests. The results suggest that family therapy enhances juvenile drug court outcomes beyond what can be achieved with a nonfamily based treatment, especially with respect to what is arguably the primary objective of juvenile drug courts: reducing criminal behavior and rearrests. More research is needed on the effectiveness of juvenile drug courts generally and on whether treatment type and family involvement influence outcomes. Clinical Trials.gov, Identified NCT01668303.
- 1 April 2010
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 38 (3) , 263-274
A randomized pilot study of the Engaging Moms Program for family drug court
- 1 April 2010
- Published by Elsevier in Journal of Substance Abuse Treatment
- Vol. 38 (3) , 263-274
A randomized pilot study of the Engaging Moms Program for family drug court
- 1 September 2009
- Published by Wiley in Juvenile & Family Court Journal
- Vol. 60 (4) , 11-23
Increasing Family Reunification for Substance‐Abusing Mothers and Their Children: Comparing Two Drug Court Interventions in Miami
This study provides a quasi‐experimental test of 80 consecutive enrollments in the Miami‐Dade (Florida) Dependency Drug Court in order to examine the impact of a family‐based and gender specific intervention, Engaging Moms Program (EMP), on drug court graduation and family reunification. We compared EMP with case management services (CMS). Results indicated that 72% of mothers in the EMP graduated from drug court, and 70% were reunified with their children. In contrast, 38% of mothers receiving CMS graduated from drug court, and 40% were reunited with their children. EMP, then, appears to be a promising family drug court intervention.
- 1 September 2009
- Published by Wiley in Juvenile & Family Court Journal
- Vol. 60 (4) , 11-23
Increasing Family Reunification for Substance‐Abusing Mothers and Their Children: Comparing Two Drug Court Interventions in Miami
This study provides a quasi‐experimental test of 80 consecutive enrollments in the Miami‐Dade (Florida) Dependency Drug Court in order to examine the impact of a family‐based and gender specific intervention, Engaging Moms Program (EMP), on drug court graduation and family reunification. We compared EMP with case management services (CMS). Results indicated that 72% of mothers in the EMP graduated from drug court, and 70% were reunified with their children. In contrast, 38% of mothers receiving CMS graduated from drug court, and 40% were reunited with their children. EMP, then, appears to be a promising family drug court intervention.
- 1 August 2003
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 71 (4) , 764-772
Enrolling and retaining mothers of substance-exposed infants in drug abuse treatment.
This study provided an experimental test of a drug abuse treatment enrollment and retention intervention in a sample of 103 Black mothers of substance-exposed infants. Significantly more women assigned to the Engaging Moms Program enrolled into drug abuse treatment than did women assigned to the control condition (88% vs. 46%). Sixty-seven percent of participants in the Engaging Moms Program received at least 4 weeks of drug abuse treatment compared with 38% of the control women. However, there were no differences between the groups 90 days following treatment entry. Logistic regressions revealed that readiness for treatment predicted both short-term and long-term treatment retention. The Engaging Moms Program has considerable promise in facilitating treatment entry and short-term retention, but it did not influence long-term retention.
- 1 August 2003
- Published by American Psychological Association (APA) in Journal of Consulting and Clinical Psychology
- Vol. 71 (4) , 764-772
Enrolling and retaining mothers of substance-exposed infants in drug abuse treatment.
This study provided an experimental test of a drug abuse treatment enrollment and retention intervention in a sample of 103 Black mothers of substance-exposed infants. Significantly more women assigned to the Engaging Moms Program enrolled into drug abuse treatment than did women assigned to the control condition (88% vs. 46%). Sixty-seven percent of participants in the Engaging Moms Program received at least 4 weeks of drug abuse treatment compared with 38% of the control women. However, there were no differences between the groups 90 days following treatment entry. Logistic regressions revealed that readiness for treatment predicted both short-term and long-term treatment retention. The Engaging Moms Program has considerable promise in facilitating treatment entry and short-term retention, but it did not influence long-term retention.
- 1 March 2001
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 40 (3) , 274-281
Predictors of Engagement in Adolescent Drug Abuse Treatment
- 1 March 2001
- Published by Elsevier in Journal of the American Academy of Child & Adolescent Psychiatry
- Vol. 40 (3) , 274-281
Predictors of Engagement in Adolescent Drug Abuse Treatment
- 1 March 2000
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 32 (1) , 25-32
Understanding Gender Differences in Adolescent Drug Abuse: Issues of Comorbidity and Family Functioning
Female adolescent drug use has increased dramatically in the last 30 years, and there is a growing consensus that the syndrome of female adolescent substance abuse is different from the well-recognized male pattern. Gender differences in patterns of comorbidity and family functioning were investigated in a sample of 95 youths (42 girls and 53 boys) referred for substance abuse treatment. The findings indicate that male and female adolescent substance users differ in several clinically meaningful ways. The results from a discriminant function analysis indicate that substance-using adolescents referred to treatment are distinguished especially by the greater degree to which girls have internalizing symptoms and family dysfunction. The clinical implications of these gender differences are articulated.
- 1 March 2000
- Published by Taylor & Francis in Journal of Psychoactive Drugs
- Vol. 32 (1) , 25-32
Understanding Gender Differences in Adolescent Drug Abuse: Issues of Comorbidity and Family Functioning
Female adolescent drug use has increased dramatically in the last 30 years, and there is a growing consensus that the syndrome of female adolescent substance abuse is different from the well-recognized male pattern. Gender differences in patterns of comorbidity and family functioning were investigated in a sample of 95 youths (42 girls and 53 boys) referred for substance abuse treatment. The findings indicate that male and female adolescent substance users differ in several clinically meaningful ways. The results from a discriminant function analysis indicate that substance-using adolescents referred to treatment are distinguished especially by the greater degree to which girls have internalizing symptoms and family dysfunction. The clinical implications of these gender differences are articulated.
- 1 January 1998
- Published by American Psychological Association (APA) in Journal of Counseling Psychology
- Vol. 45 (1) , 104-114
Treatment adherence and differentiation in individual versus family therapy for adolescent substance abuse.
- 1 January 1998
- Published by American Psychological Association (APA) in Journal of Counseling Psychology
- Vol. 45 (1) , 104-114
Treatment adherence and differentiation in individual versus family therapy for adolescent substance abuse.
- 1 January 1996
- Published by American Psychological Association (APA) in Journal of Family Psychology
- Vol. 10 (1) , 12-27
Changes in parenting practices and adolescent drug abuse during multidimensional family therapy.
- 1 January 1996
- Published by American Psychological Association (APA) in Journal of Family Psychology
- Vol. 10 (1) , 12-27
Changes in parenting practices and adolescent drug abuse during multidimensional family therapy.